Testing to diagnose tuberculosis in Swiss children
Part of Infections clinical trials.
This trial studies how to diagnose tuberculosis (TB) in children and teens when they are being checked after possible exposure or because TB is suspected. It may help doctors figure out faster and more accurately who has TB infection or disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You/your child must be under 18 years old
- You/your child is currently being evaluated for TB exposure or suspected TB
- You/your child has not already started TB medicine for this current situation
- You/your child has not been treated for TB in the past
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing new ways to quickly diagnose TB in children under 15. It aims to find better tests that can be used at clinics, especially for kids who may not have obvious symptoms.
This study tests new ways to diagnose and monitor tuberculosis (TB) in children under 15 who might have TB in their lungs. The goal is to improve how we find and treat TB so children get better faster.
This study tests new, faster ways to diagnose tuberculosis (TB) using samples like sputum (mucus from your lungs), tongue swabs, and urine. It aims to see if these new tests can find TB more accurately than current methods, which could help you get the right treatment sooner.
This study is looking at how a simple blood test can help monitor tuberculosis (TB) treatment. It may help doctors know sooner if the treatment is working.
This study tests new tools that can check for tuberculosis (TB) more quickly at or near where care happens. It includes people with cough or TB risk factors, and also the health workers who perform TB testing, to see how well the tests work and how easy they are to use.
This study tests rapid TB screening and lab-style diagnostic methods to see how well they find TB disease and TB that is resistant to rifampin (a key TB drug). It may help doctors diagnose TB faster and more accurately, especially in people at higher risk.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.